Talk:Chronic prostatitis/chronic pelvic pain syndrome

This MedLibrary.org supplementary page on Talk:Chronic prostatitis/chronic pelvic pain syndrome is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

This is the talk page for discussing improvements to the Chronic prostatitis/chronic pelvic pain syndrome article.

Article policies
WikiProject Medicine This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess.
C This page has been rated as C-Class on the quality assessment scale
Mid This article has been rated as Mid-importance on the importance assessment scale

Major new overview study published in top journal

The Journal of Urology (known as "the white journal" by urologists since it is one of the top medical journals in the world) has just published a major new study that looks back over 30 years of research into this field. You can read it here. I think this should be used as a starting point for any further editing of the page. If there is no objection, I shall use it as a reference for a lot of future changes. ► RATEL ◄ 14:38, 28 April 2008 (UTC)


NIH alfusozin study

Objection to posting findings of the study because not yet published in a journal. This was a large, multi-center, NIH run study whose findings have a direct impact on patient care today. Abstract is published in the Journal of Urology AUA edition. Not reasonable to wait on every bit of medical evidence to go through the 6-12 months it takes to be published in a journal if level of quality (patient numbers, study design, track record of investigators) is strong enough. Is this not more important than a list of famous dead people who may have had prostatitis based on newspaper accounts? I completely agree that minor abstracts should not be given the weight of peer reviewed journal articles and that not all journal articles are of equal weight. I would also support removing the information if no article is forthcoming. Nevertheless, I believe that deleting this edit sets the bar too high, and would call into question some of the other more speculative parts of the CPPS wiki entry. Wlosy (talk) 15:32, 21 May 2008 (UTC)

Failure of alfusozin does not mean other alpha blockers will fail also. Alfusozin is relatively selective for the alpha1a receptor subtype. Alpha receptors that control pain in the spinal cord may be other subtypes. Note that studies of less selective alpha blockers in CPPS (Cardura, Hytrin) while smaller in numbers, were all positive studies. Wlosy (talk) 22:03, 26 May 2008 (UTC)

Actually, the abstract ends with the conclusion:

This large NIH/NIDDK sponsored multicenter randomized placebo controlled North American trial will provide an evidence based foundation to help physicians decide whether or not to prescribe alpha-blockers for men with newly diagnosed CP/CPPS.

The inference that the study relates to all alpha blockers may justifiably be drawn. However, I see no problem leaving the edit you made, for now.► RATEL ◄ 22:40, 26 May 2008 (UTC)

Wikipedia content modification information:

  • This page was last modified on 13 September 2008, at 09:34.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Talk:Chronic prostatitis/chronic pelvic pain syndrome".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.